ȸ»öÁúô¼ö¿°ÀÇ º´·ÂÀÌ Àִ ȯÀÚ¿¡¼­ ¹ß»ýÇÑ ±Ù·Â ¾àÈ­: ¼Ò¾Æ¸¶ºñÈÄÁõÈıº(Post-polio Syndrome)°ú ÇǺαٿ°ÀÇ °¨º°
Muscle Weakness in a Patient with History of Poliomyelitis:A Differential Diagnosis for Post-polio Syndrome (PPS) and Dermatomyositis

´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö 2014³â 21±Ç 3È£ p.147 ~ p.150

¾È»óÈñ(An Sang-Hee) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç
³ªÇÏ¿µ(Na Ha-Young) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç
°­¼ºÈñ(Kang Seong-Hui) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç
¹Ú¼ö¿¬(Park Soo-Youn) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç
À¯Çü¹Î(Yu Hyung-Min) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç
ÀÓäȣ(Lim Chae-Ho) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç
±èÁö¿Ï(Kim Ji-Wan) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç
±Ç¼¼¿õ(Kwon Se-Woong) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç
ÀÌÁ¤È­(Lee Jung-Hwa) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç
±èÇØ¸²(Kim Hae-Rim) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç
ÀÌ»óÇå(Lee Sang-Heon) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç

Abstract

Dermatomyositis (DM) is an idiopathic inflammatory myo-pathy, characterized by inflammation of the proximal skel-etal muscles and typical skin manifestations, which results in symmetric muscle weakness. A 43- year-old man was presented with skin rash and left leg weakness, and he had a history of poliomyelitis. Initially, he was diagnosed as having post-polio syndrome (PPS) due to unilateral muscle weakness and a result of an the electromyography (EMG), which had shown patterns of PPS. After 4 months with conservative therapy for PPS, weakness of bilateral upper arms had developed and skin rashes on his entire body had aggravated and progressed. He was diagnosed as hav-ing dermatomyositis, based on elevated muscle enzyme lev-els, typical skin rashes, and typical EMG findings, which indicated muscle disease. When a patient with previous po-liomyelitis has a newly developed muscle weakness or pain, we should consider various possible causes other than PPS.

Ű¿öµå

Dermatomyositis, Post-polio syndrome, Poliomyelitis, Skin rash, Muscle weakness
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå